BOSTON SCIENTIFIC CORP — Director's Dealing 2020

Sep 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2020-09-01

Reporting Person: Mirviss Jeffrey B. (EVP&Pres, Periph Intervent)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-20	Common Stock	G	165.0000	$0.0000	Disposed	115622.0000	Direct
2020-09-01	Common Stock	M	60000.0000	$6.3100	Acquired	175622.0000	Direct
2020-09-01	Common Stock	S	60000.0000	$40.9338	Disposed	115622.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-01	Stock Option (Right to Buy)	$6.3100	M	60000.0000	Disposed	2020-10-25	Common Stock (60000.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	25000.0000	Indirect

Footnotes

F1: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.

F2: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $40.70 to $41.05, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Grant to reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on October 25, 2011, the first anniversary of the date of grant.